Picture Berlin Partner Top News Cambrium Biobased AI Materials 650x100px

Organisation › Details

Monte Rosa Therapeutics (Group)

https://www.monterosatx.com

	Start	2018-01-01 established
	Predecessor	Versant Ridgeline Discovery Engine Basel
	Industry	targeted protein degradation drug (TPD drug)
	Industry 2	protein degradation technology
	Person	Warmuth, Markus (Monte Rosa Therapeutics 202009 CEO + Venture Partner at Versant Ventures before Eisai/H3 Biomedicine)

	Region	Boston, MA
	Country	United States (USA)
	Street	645 Summer Street Suite 102
	City	02210 Boston, MA
	Tel	+1-617-949-2643
		Address record changed: 2021-06-25

Basic data	Employees	C: 51 to 100 (2021-06-21)
	Currency	USD
	Profit	-35,879,000 (2020-12-31)
	Cash	41,699,000 (2020-12-31)


		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x200px

More documents for Monte Rosa Therapeutics (Group)

[1] Monte Rosa Therapeutics, Inc.. (6/23/21). "Press Release: Monte Rosa Therapeutics Announces Pricing of Initial Public Offering". Boston, MA....
[2] Monte Rosa Therapeutics. (3/12/21). "Press Release: Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform". Boston, MA....
[3] Monte Rosa Therapeutics. (9/24/20). "Press Release: Monte Rosa Therapeutics Announces $96 Million Series B Financing to Advance Small Molecule-based Protein Degradation Platform". Boston, MA....
[4] Monte Rosa Therapeutics. (5/26/20). "Press Release: Monte Rosa Therapeutics Discloses $32.5 Million Financing. Launched from Versant’s Ridgeline Discovery Engine". Boston, MA & Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)